GlassScriptPhysician profile
Cho Rok Kim
NPI 1437787009
$1,397.23
in general payments reported to CMS, 2019-2025
16 companies · $561 in 2025
The $561 reported for 2025 was more than what 75% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.96 · 2022: $40.61 · 2023: $231 · 2024: $538 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,329.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $342.95 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $234.73 | 2023-2025 | |
| Lilly USA, LLC | $178.88 | 2023-2025 | Mounjaro, Zepbound |
| Amgen INC. | $110.99 | 2023-2025 | Otezla, Repatha, Repatha |
| Glaxosmithkline, LLC. | $91.29 | 2023-2025 | Shingrix, Arexvy |
| Exact Sciences Corporation | $91.22 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Novo Nordisk INC | $86.34 | 2025 | Rybelsus, Ozempic |
| Axsome Therapeutics, INC. | $53.59 | 2025 | Auvelity |
| Noah Medical Corporation | $46.43 | 2023 | |
| Phadia US INC. | $29.71 | 2025 | Immunocap |
| Emd Serono, INC. | $26.96 | 2021 | |
| Astellas Pharma US INC | $25.32 | 2024 | Veozah |
| Merck Sharp & Dohme LLC | $23.92 | 2024 | Gardasil, Capvaxive, Gardasil 9 |
| Morphosys, US INC. | $23.25 | 2022 | |
| Seagen INC. | $17.36 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $14.29 | 2024 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cho Rok Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.